In the complex world of medical diagnosis, few conditions present as many challenges as systemic lupus erythematosus, commonly known as lupus. This autoimmune disease has earned its reputation as the ...

Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker assays designed to improve the detection of systemic lupus erythematosus ...

UCI Health has opened a clinical trial to test an investigational cell therapy for lupus with the potential to give patients long-term remission of symptoms.

Lupus, which is difficult to treat and on the rise, is part of the group of autoimmune diseases that affect millions of ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.